Association of cys 311 ser polymorphism of paraoxonase-2 gene with the risk of coronary artery disease.
暂无分享,去创建一个
Ali Jalilian | R. Heshmat | A. Jalilian | Ramin Heshmat | Ebrahim Javadi | Mohamad Akrami | Hossin Fakhrzadeh | Mazaher Rahmani | Fatemeh Bandarian | F. Bandarian | E. Javadi | M. Rahmani | H. Fakhrzadeh | M. Akrami
[1] P. Durrington,et al. Paraoxonase and coronary heart disease. , 1998, Atherosclerosis. Supplements.
[2] E. Trabetti,et al. Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction , 2004, European journal of clinical investigation.
[3] P. Edwards,et al. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[4] M. Jauhiainen,et al. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. , 1996, The Journal of clinical investigation.
[5] S. Reddy,et al. Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cell-mediated Oxidative Modification of Low Density Lipoprotein* , 2001, The Journal of Biological Chemistry.
[6] D. Shih,et al. Human Paraoxonase-3 Is an HDL-Associated Enzyme With Biological Activity Similar to Paraoxonase-1 Protein but Is Not Regulated by Oxidized Lipids , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[7] Dan S. Tawfik,et al. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes , 2004, Nature Structural &Molecular Biology.
[8] D. Sanghera,et al. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. , 1998, American journal of human genetics.
[9] S. Scherer,et al. Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites. , 1998, Atherosclerosis.
[10] S. Scherer,et al. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. , 1998, Gene.
[11] B. La Du,et al. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. , 1996, Genomics.
[12] J. Kastelein,et al. PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients. , 2001, Atherosclerosis.
[13] A. Marciniak,et al. Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration. , 2002, Acta biochimica Polonica.
[14] B. La Du,et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. , 1998, The Journal of clinical investigation.
[15] M. Price,et al. New strategies in managing and preventing atherosclerosis: focus on HDL. , 2002, Reviews in cardiovascular medicine.
[16] M. Keifer,et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin , 1996, Nature Genetics.
[17] S. Reis,et al. Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. , 2003, American journal of human genetics.
[18] C. Abbott,et al. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. , 1993, Atherosclerosis.